- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.08. | Heartbeam director sells over $4,900 in company stock | 1 | Investing.com | ||
| 27.08. | Heartbeam executive sells shares worth over $6,400 | 1 | Investing.com | ||
| 15.08. | Earnings call: HeartBeam anticipates AIMIGo launch, reports $5M loss | 1 | Investing.com | ||
| 15.08. | Heartbeam Inc reports results for the quarter ended in June - Earnings Summary | 1 | Reuters | ||
| 14.08. | HeartBeam GAAP EPS of -$0.19 misses by $0.02 | 1 | Seeking Alpha | ||
| 14.08. | HeartBeam Reports Second Quarter 2024 Results | 242 | Business Wire | SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has reported... ► Artikel lesen | |
| 01.07. | HeartBeam added to Russell Microcap Index | 1 | Seeking Alpha | ||
| 18.06. | HeartBeam, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.05. | HeartBeam AI with VCG outperforms cardiologists in detecting arrhythmias | 1 | MassDevice | ||
| 13.05. | Earnings call: HeartBeam reports progress on FDA clearance, Q1 financials | 1 | Investing.com | ||
| 10.05. | Heartbeam Inc reports results for the quarter ended in March - Earnings Summary | 1 | Reuters | ||
| 09.05. | HeartBeam Reports First Quarter 2024 Results | 84 | Business Wire | SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has reported... ► Artikel lesen | |
| 02.05. | HeartBeam, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 09.04. | HeartBeam AI Combined With Vectorcardiography Delivers Equivalent Performance To 12-lead ECG | 1 | RTTNews | ||
| 09.04. | HeartBeam reports positive results of its AI capabilities for detecting arrhythmias | 1 | Seeking Alpha | ||
| 20.03. | Heartbeam Inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
| 20.03. | HeartBeam reports Q4 results | 1 | Seeking Alpha | ||
| 20.03. | Recap: HeartBeam Q4 Earnings | 1 | Benzinga.com | ||
| 20.03. | HeartBeam, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 20.03. | HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results | 103 | Business Wire | SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has reported... ► Artikel lesen |
Seite:
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 40,560 | -2,31 % | Eckert & Ziegler: Börsengang von Pentixapharm in wenigen Wochen möglich | Der Börsengang von Pentixapharm, einer Tochtergesellschaft von Eckert & Ziegler (E&Z), ist schon seit 2023 Thema. Wichtige Steine auf dem Weg zur Abspaltung und damit auch dem Börsengang sind aus dem... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,170 | -2,82 % | Atossa Therapeutics, Inc.: Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference | ||
| EMEIS | 7,565 | -0,33 % | Jean-Marc Boursier Appointed emeis' Chief Financial Officer | Regulatory News:
emeis (Paris:EMEIS):
Effective 2 September, Jean-Marc Boursier joins Laurent Guillot and his management team as Group Chief Financial Officer (CFO). Jean-Marc will take over... ► Artikel lesen | |
| NANO-X IMAGING | 5,885 | -1,59 % | Nano-X Imaging Ltd. (NNOX): An Under The Radar AI Stock You Should Pay Attention To | ||
| BUTTERFLY NETWORK | 1,615 | -3,29 % | Butterfly Network Inc.: Butterfly Network bringt seine nächste Generation Butterfly iQ3 in Europa auf den Markt | Butterfly iQ3 basiert auf der Ultrasound-on-Chip-Technologie der nächsten Generation, die sich durch eine einzigartige Bildqualität, neue 3D-Bildgebungsfunktionen und ein kompakteres und leichteres... ► Artikel lesen | |
| GOODRX | 7,710 | -3,50 % | Spectrum Equity sells shares in GoodRx Holdings worth over $83k | ||
| CARMAT | 2,400 | +0,42 % | CARMAT Publishes Its 2024 Half-Year Results and Provides an Update on Its Outlook | Half-year sales of €3.3 million, exceeding 2023 full-year sales
20 implants of the Aeson® artificial heart performed in the first half of 2024
17% cash-burn1 reduction compared to... ► Artikel lesen | |
| HYPERFINE | 0,900 | -2,17 % | Hyperfine, Inc.: Hyperfine Expands European Market Reach with Additional Strategic Distributor Partners | New distribution partnerships further global expansion plans for the Swoop system, growing the reach of Hyperfine to a total of twelve European countries
Hyperfine (Nasdaq: HYPR), the groundbreaking... ► Artikel lesen | |
| MIMEDX | 6,150 | -3,60 % | MiMedx Group, Inc: MIMEDX Announces Second Quarter 2024 Operating and Financial Results | Net Sales of $87 Million Grew 7% Year-Over-Year for the Second Quarter Second Quarter GAAP Net Income and Earnings Per Share were $18 Million and $0.12, Respectively Second Quarter Adjusted EBITDA... ► Artikel lesen | |
| PROGYNY | 23,180 | -2,15 % | Here's What Affected Progyny's (PGNY) Share Price in Q2 | ||
| PROCEPT BIOROBOTICS | 76,58 | +0,30 % | Procept Biorobotics director Rohit Desai sells over $7.7 million in company stock | ||
| ATRICURE | 26,260 | +0,46 % | AtriCure, Inc.: AtriCure erhält eine erweiterte CE-Kennzeichnung für AtriClip-Geräte zur Reduzierung von Schlaganfällen bei Patienten mit Vorhofflimmern | Erweiterte Indikation auf Basis von zahlreichen klinischen Nachweisen für AtriClip-Geräte AtriCure, Inc. (Nasdaq: ATRC), ein führender Innovator im Bereich chirurgischer Behandlungen und Therapien... ► Artikel lesen | |
| BIOMERICA | 0,355 | -7,29 % | Saudi Arabia approves Biomerica's prostate cancer test | ||
| PROPHASE LABS | 2,200 | -2,65 % | ProPhase Labs, Inc.: ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated | Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database... ► Artikel lesen |
Das Unternehmen HEARTBEAM INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -6,88 % bei einem Aktienkurs von 2,300 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HEARTBEAM INC finden Sie auf Wallstreet Online.
